Amphastar officer proposes $366K stock sale
The notice’s three-month transaction history lists sales dated August 7, September 21 and November 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A Form 144 signed by UBS Financial Services, Inc. as attorney-in-fact for William J. Peters, an officer of Amphastar Pharmaceuticals, Inc. (AMPH), reports a proposed sale of 12,631 common shares, with an aggregate market value of $366,189, on November 5, 2026, through NASDAQ. It also lists three common-stock sales during the prior three months: 8,180 shares on August 7, 2026; 4,139 shares on September 21, 2026; and 16,000 shares on November 4, 2026.
Key Figures
Key Terms
Rule 144 regulatory
RSU Vesting technical
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What AMPH stock sales did William J. Peters report during the prior three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.